Cambridge’s Next Biotech Beacon Gains Altitude
Led locally by Bill Kane, Blackstone-owned BioMed Realty is building one of Cambridge’s most notable new projects, the 585 Kendall tower leased to Takeda Pharmaceuticals.
A Retail to Research Swap at CambridgeSide
Under the direction of Clement Fourny, SmartLabs has begun transforming the top floor of former retail space at the CambridgeSide property into a new life science research center for a broad spectrum of startups.
Developer Tests Porter Square for Lab Project
A Cambridge developer is testing the Porter Square area as a new growth node for life science development with a proposal for a 42,000-square-foot lab project.
Breakthrough Buys East Cambridge Property for $133M
A life science developer that’s partnering on Harvard University’s next Allston project is adding an East Cambridge office property to its real estate portfolio.
Alexandria to Buy East Cambridge Offices for $815M
Life science developer Alexandria Real Estate Equities is finding new opportunities for growth in the Cambridge industry epicenter with an agreement to buy the One Charles Park and One Rogers Street office buildings for $815 million and convert them to lab space.
Cambridge Crossing Tops Off Sanofi Buildings
Construction crews marked a milestone in the development of Sanofi’s new U.S. research headquarters that will house 3,000 employees at Cambridge Crossing.
Cambridge Crossing Lands Another Life Science Research Hub
Bristol-Myers Squibb will consolidate a pair of Cambridge facilities at a new 504,000-square-foot office-lab building under construction at Cambridge Crossing, becoming the fourth major commercial tenant of the DivcoWest development.
Life Science Developer Buys 26-Acre Alewife Site
A Cambridge construction materials manufacturer will occupy its 290,000-square-foot headquarters rent-free for 18 months after the pending sale of the property for $125 million to a life science developer.
